• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄膜黑色素瘤中的浸润淋巴细胞和抗原表达

Infiltrating lymphocytes and antigen expression in uveal melanoma.

作者信息

Meecham W J, Char D H, Kaleta-Michaels S

机构信息

Department of Ophthalmology, University of California, San Francisco 49143-0730.

出版信息

Ophthalmic Res. 1992;24(1):20-6. doi: 10.1159/000267140.

DOI:10.1159/000267140
PMID:1608588
Abstract

Monoclonal antibodies and flow cytometry were used to study lymphocyte, monocyte and tumor cell antigen expression in uveal melanoma. Forty-one melanomas were studied after various forms of treatment. An antimelanoma antibody, 13A3E, stained 81.7% of the cells. Tumors treated with helium ions or 125I plaques had 13A3E staining reduced to 62.5%, p = 0.011. HLA-A,B,C stained 85.4%, and HLA-DR stained 7.0% of the cells. T cells (CD3 positive) comprised 4.5% (range 0.1-29.2%) of total cell population. Natural killer (NK) cells, B cells and macrophages were present in small numbers (mean less than 2.5% in each case). Tumors with numerous T cells (greater than 5%), were used for T cell subtype studies. The mean helper/inducer (CD4) to cytotoxic/suppressor (CD8) ratio was 1.00 (range 0.11-3.15). CD8 decreased, and CD4 increased with age in unirradiated tumors (p less than 0.02).

摘要

采用单克隆抗体和流式细胞术研究葡萄膜黑色素瘤中淋巴细胞、单核细胞和肿瘤细胞的抗原表达。对41例黑色素瘤进行了各种形式治疗后进行研究。一种抗黑色素瘤抗体13A3E可使81.7%的细胞染色。经氦离子或碘-125斑块治疗的肿瘤,13A3E染色降至62.5%,p = 0.011。HLA-A、B、C染色阳性率为85.4%,HLA-DR染色阳性率为7.0%。T细胞(CD3阳性)占总细胞群的4.5%(范围0.1 - 29.2%)。自然杀伤(NK)细胞、B细胞和巨噬细胞数量较少(每种情况平均少于2.5%)。对T细胞数量较多(大于5%)的肿瘤进行T细胞亚群研究。辅助/诱导(CD4)与细胞毒性/抑制(CD8)的平均比值为1.00(范围0.11 - 3.15)。在未接受照射的肿瘤中,CD随年龄增长而降低,CD4随年龄增长而升高(p < 0.02)。

相似文献

1
Infiltrating lymphocytes and antigen expression in uveal melanoma.葡萄膜黑色素瘤中的浸润淋巴细胞和抗原表达
Ophthalmic Res. 1992;24(1):20-6. doi: 10.1159/000267140.
2
HLA expression and tumor-infiltrating immune cells in uveal melanoma.葡萄膜黑色素瘤中的HLA表达与肿瘤浸润免疫细胞
Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):34-42. doi: 10.1007/BF00186516.
3
HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.原发性葡萄膜黑色素瘤、其细胞系及其四处转移灶中的人类白细胞抗原(HLA)表达情况。
Br J Ophthalmol. 1997 Nov;81(11):989-93. doi: 10.1136/bjo.81.11.989.
4
Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.葡萄膜黑色素瘤中的主要组织相容性抗原和抗原加工分子
Clin Cancer Res. 2003 Sep 15;9(11):4159-64.
5
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.不同亚群的肿瘤浸润淋巴细胞与黑色素瘤中的巨噬细胞浸润和单体型 3 相关。
Invest Ophthalmol Vis Sci. 2012 Aug 9;53(9):5370-8. doi: 10.1167/iovs.11-9280.
6
Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.用一组针对皮肤黑色素瘤的单克隆抗体分析葡萄膜黑色素瘤病变的表面抗原谱。
Anticancer Res. 1990 Jan-Feb;10(1):81-9.
7
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.3号染色体单体性与炎症表型在葡萄膜黑色素瘤中共同出现。
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):505-10. doi: 10.1167/iovs.07-0786.
8
Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.使用抗皮肤黑色素瘤相关抗原和抗 HLA 单克隆抗体分析葡萄膜黑色素瘤病变的抗原谱。
Cancer Res. 1989 Mar 1;49(5):1269-74.
9
Analysis of lymphocytic infiltration in uveal melanoma.
Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2106-10.
10
Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.小鼠模型中人类葡萄膜黑色素瘤细胞的自然杀伤细胞敏感性与转移之间的关系
Invest Ophthalmol Vis Sci. 1995 Feb;36(2):435-41.

引用本文的文献

1
Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease.原发性葡萄膜黑色素瘤的经玻璃体视网膜脉络膜活检显示,低风险疾病中低HLA I类分子与高自然杀伤细胞丰度之间存在关联。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):24. doi: 10.1167/iovs.66.2.24.
2
Identifying biomarkers for treatment of uveal melanoma by T cell engager using a QSP model.使用 QSP 模型通过 T 细胞衔接器鉴定葡萄膜黑色素瘤治疗的生物标志物。
NPJ Syst Biol Appl. 2024 Sep 30;10(1):108. doi: 10.1038/s41540-024-00434-5.
3
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma.
从分子生物学到葡萄膜黑色素瘤的新型免疫疗法和纳米医学。
Curr Oncol. 2024 Feb 1;31(2):778-800. doi: 10.3390/curroncol31020058.
4
Identification of co-expressed gene networks promoting CD8 T cell infiltration and having prognostic value in uveal melanoma.鉴定促进 CD8 T 细胞浸润并具有葡萄膜黑色素瘤预后价值的共表达基因网络。
BMC Ophthalmol. 2023 Aug 10;23(1):354. doi: 10.1186/s12886-023-03098-7.
5
Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.生物信息学分析揭示肿瘤浸润免疫细胞在葡萄膜黑色素瘤进展中的核心作用。
J Immunol Res. 2021 Jun 11;2021:9920234. doi: 10.1155/2021/9920234. eCollection 2021.
6
Role of Natural Killer Cells in Uveal Melanoma.自然杀伤细胞在葡萄膜黑色素瘤中的作用。
Cancers (Basel). 2020 Dec 9;12(12):3694. doi: 10.3390/cancers12123694.
7
The Role of Immune Checkpoint Blockade in Uveal Melanoma.免疫检查点阻断在葡萄膜黑色素瘤中的作用。
Int J Mol Sci. 2020 Jan 29;21(3):879. doi: 10.3390/ijms21030879.
8
Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes.原发葡萄膜黑色素瘤的肿瘤浸润淋巴细胞的分子分析。
Oncoimmunology. 2014 Oct 31;8(10):e947169. doi: 10.4161/21624011.2014.947169. eCollection 2019.
9
HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.葡萄膜黑色素瘤中的HLA表达:恶性肿瘤的指标及可调节的免疫靶点
Cancers (Basel). 2019 Aug 7;11(8):1132. doi: 10.3390/cancers11081132.
10
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?葡萄膜黑色素瘤的免疫基础:免疫治疗是否有理论依据?
Cancers (Basel). 2019 Jul 26;11(8):1055. doi: 10.3390/cancers11081055.